MGLL and Anxiety: Pharmacological enhancement of 2-AG signaling by inhibiting 2-AG-deactivating enzyme monoacylglycerol lipase (MGL) with JZL184, normalized this synaptic defect and corrected behavioral abnormalities (hyperactivity and abnormal anxiety) in fragile X mice (Jung et al., 2012).